ARCHIVES

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

Fisher, Hallman Lecture At annual ASCO/AACR Meeting

May 9, 1980

R01 Payline To Increase From 21st to 22nd Percentile; Barcelona Hospital Wins BMS Cancer Research Grant

June 14, 2002

Guideline Revisions or Outstanding Investigator Grant Still Controversial

December 9, 1983

Taxotere Encouraging, CPT-11, Other Agents Entering Trials; Chabner

July 10, 1992

NCI Budget: How Did NCI Spend Last Year’s Increase? Klausner Lists Activities

November 19, 1999

Proposed Surveillance Model Aims To Reduce Post-Treatment Pain

April 27, 2012